| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4469915
Max Phase: Preclinical
Molecular Formula: C20H17NO7
Molecular Weight: 383.36
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Cc1c(CC(=O)O)c(=O)oc2c(C)c(OCc3cccc([N+](=O)[O-])c3)ccc12
Standard InChI: InChI=1S/C20H17NO7/c1-11-15-6-7-17(27-10-13-4-3-5-14(8-13)21(25)26)12(2)19(15)28-20(24)16(11)9-18(22)23/h3-8H,9-10H2,1-2H3,(H,22,23)
Standard InChI Key: FXVXNIHWINSHOT-UHFFFAOYSA-N
Associated Targets(non-human)
Chloride anion exchanger 100 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 383.36 | Molecular Weight (Monoisotopic): 383.1005 | AlogP: 3.52 | #Rotatable Bonds: 6 |
| Polar Surface Area: 119.88 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.61 | CX Basic pKa: | CX LogP: 3.62 | CX LogD: 0.28 |
| Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.39 | Np Likeness Score: -0.80 |
References
| 1. Lee S, Cil O, Haggie PM, Verkman AS.. (2019) 4,8-Dimethylcoumarin Inhibitors of Intestinal Anion Exchanger slc26a3 (Downregulated in Adenoma) for Anti-Absorptive Therapy of Constipation., 62 (17): [PMID:31389695] [10.1021/acs.jmedchem.9b01192] |
| 2. (2021) Slc26a3 inhibitors and use thereof, |
Source
Source(2):